Top compounds associated with response to TXNDC17


Feature Type Standardized
Nominal ANOVA
mRNA vorapaxar CTRPv2 pan-cancer AAC -0.1 0.009
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.09 0.009
mRNA BMS-754807 CTRPv2 pan-cancer AAC -0.092 0.009
mRNA FH535 GDSC1000 pan-cancer AAC 0.091 0.009
mRNA MI-2 CTRPv2 pan-cancer AAC -0.14 0.009
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.088 0.01
mRNA NG-25 GDSC1000 pan-cancer AAC -0.078 0.01
mRNA TKI258 CCLE pan-cancer AAC -0.12 0.01
mRNA piperlongumine GDSC1000 pan-cancer AAC 0.085 0.01
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.09 0.01
Download CSV